Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Becton Dickinson & Co.

www.bd.com

Latest From Becton Dickinson & Co.

FDA Grants EUA For Roche’s Coronavirus Antibody Test

The company says the serology test has a specificity of 99.8% and sensitivity of 100%

Research & Development Regulation

Abbott Rolls Out COVID-19 Antibody Test

Abbott has launched its first COVID-19 antibody test to help determine if a person has been previously infected with the virus. The diagnostics giant said it intends to ship a total of 4 million tests in April.

Coronavirus COVID-19 Diagnostics

BD Alerts Homeland Security To Vulnerability On Hospital Drug Dispensers

Low-skilled malicious hackers with physical access to certain Becton Dickinson hospital drug dispensers could access sensitive patient data and even alter them, a report from the US Department of Homeland Security says. The company and DHS are advising users to put extra measures in place to mitigate the threat while BD develops a software patch.

Quality Control Companies

COVID-19: Nanomix Wins BARDA Funding For Mobile Point-Of-Care Assay

The US government’s Biomedical Advanced Research and Development Authority has awarded Nanomix up to $570,000 to develop a SARS-CoV-2 test for its portable, rapid Nanomix eLab analyzer.

Coronavirus COVID-19 Infectious Diseases
See All

Company Information

UsernamePublicRestriction

Register